Texas Instruments Incorporated

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +45

Texas Instruments (TXN) Faces A Valuation Split, Is The Stock Still Undervalued?

AI-generated analysis

πŸ“‰ TXN shares slipped 1.07% recently, with momentum cooling as the stock is down 7.86% over 30 days and 19.26% over 90 days.

πŸš€ The company has achieved a year-to-date share price return of 46.84% and a one-year total shareholder return of 48.32%.

πŸ’° One valuation model prices TXN well below an implied fair value of $435.69 versus the latest close of $260.67.

🏭 Texas Instruments is executing a multiyear capacity-expansion cycle involving U.S.-based 300mm analog manufacturing to improve cost efficiency and supply-chain resilience.

πŸ“ˆ The bullish thesis assumes an 11% revenue growth rate, a 42% profit margin, and earnings growth expectations of 17.2% per year.

βš–οΈ An alternative SWS DCF model estimates a fair value of $239.62, suggesting the current stock price may be overvalued.

πŸ›‘οΈ The company maintains diversified end-market exposure across industrial, automotive, aerospace/defense, and energy infrastructure sectors.

⚠️ Key risks to the bullish narrative include factory spending running over budget or slower-than-hoped AI-related demand materialization.

Bullish Signals
  • The stock has delivered a strong year-to-date return of 46.84% and a one-year total shareholder return of 48.32%, reflecting a powerful longer-term run.
  • A prominent valuation view suggests the company is priced well below an implied fair value of $435.69 compared to its recent close of $260.67, indicating potential upside.
  • The buildout of U.S.-based 300mm analog manufacturing is expected to structurally improve cost efficiency, support higher gross margins, and increase supply-chain resilience.
  • Despite slower top-line growth compared to the wider market, TXN boasts a high forecast return on equity of 43.4% and diversified end-market exposure.
Risk Factors
  • Recent momentum has cooled with the share price down 7.86% over 30 days and 19.26% over 90 days, hinting at investor reassessment of growth expectations.
  • The current capacity-expansion cycle is temporarily suppressing free cash flow, creating near-term financial headwinds despite long-term strategic benefits.
  • An alternative SWS DCF model estimates a fair value of $239.62, which screens the current stock price as overvalued rather than cheap.
  • Revenue growth forecasts of 11.8% per year trail both the wider US market at 13.3% and faster-growing semiconductor peers.
Full Analysis
Texas Instruments (TXN) shares recently slipped 1.07%, trailing broader indices as investor attention shifts to upcoming earnings reports regarding demand in industrial, automotive, and data center markets. Despite a recent 30-day decline of 7.86% and a 90-day drop of 19.26%, the company has delivered a strong year-to-date return of 46.84% and a one-year total shareholder return of 48.32%. This divergence suggests investors are currently reassessing growth expectations and risk profiles surrounding AI-driven demand across key sectors following a powerful rally. The article highlights a significant valuation split regarding TXN, with one prominent view suggesting the stock is priced well below an implied fair value of $435.69 compared to its recent close of $260.67. This bullish narrative attributes the current lower price to a multiyear capacity-expansion cycle that temporarily suppresses free cash flow while enhancing long-term competitive positioning through U.S.-based 300mm analog manufacturing. Proponents argue that as these assets ramp and utilization normalizes, TXN should regain its historical free-cash-flow profile, supported by diversified end-market exposure. However, the valuation outlook is mixed, with another framework (SWS DCF model) estimating a fair value of $239.62, which would classify the current price as overvalued. The bullish thesis relies on specific assumptions including an 11% revenue growth rate and a 42% profit margin, betting that high-margin analog products and internal manufacturing justify paying up for quality despite slower top-line growth compared to the wider US market. Conversely, risks include factory spending running over budget or AI-related demand materializing more slowly than hoped.